JODIE GAHN-STAHLEY: Open Payments
NPI 1508012865 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 28 payments from 16 companies in 2025. Trend: 2023 $900 · 2024 $737 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $136 |
| Novo Nordisk Inc | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Seqirus USA Inc | 2 | $45 |
| Edwards Lifesciences Corporation | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
Products named: VRAYLAR, REXULTI, QULIPTA, CAPLYTA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Sunosi, CREXONT, Cologuard Collection Kit.
Industry payments across CO — which companies pay providers there.
